Form 4: Encompass Health EVP Acquires Stock Options
SEC Filing
Douglas E. Coltharp, EVP & Chief Financial Officer of Encompass Health Corp, reports acquisition of non-qualified stock options.
Summary
- Douglas E. Coltharp, the EVP & Chief Financial Officer of Encompass Health Corp, filed a Form 4.
- The filing reports the acquisition of 12,407 non-qualified stock options on March 4, 2025, at an exercise price of $98.45.
- These options become exercisable in equal annual installments over a three-year period starting March 4, 2026.
- The options expire on March 4, 2035.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard regulatory filing reflecting an executive's compensation and investment in the company.
Positives
- The acquisition of stock options by a high-ranking executive could be interpreted as a sign of confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates an executive's investment in the company's stock, aligning their interests with those of shareholders.
Stakeholder Impact
- The acquisition of stock options by an executive can positively influence shareholder sentiment, as it aligns management's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 03/04/2025 | Date of transaction: acquisition of stock options. |
| 03/04/2026 | First vesting date for the stock options. |
| 03/04/2035 | Expiration date of the stock options. |
| 03/05/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.